ABC | Volume 114, Nº4, April 2020

Original Article Correia et al. CA lesions and AF recurrence - a meta-analysis Arq Bras Cardiol. 2020; 114(4):627-635 23. He X, Zhou Y, Chen Y, Wu L, Huang Y, He J. Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol. 2016;46(3):267-74. 24. Eitel C, Hindricks G, Grothoff M, Gutberlet M, Sommer P. Catheter ablation guided by real-time MRI. Curr Cardiol Rep. 2014;16(8):511. 25. Ramirez FD, Birnie DH, Nair GM, Szczotka A, Redpath CJ, SadekMM, et al. Efficacy and safety of driver-guided catheter ablation for atrial fibrillation: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28(12):1371-8. 26. Phung TN, Moyer CB, Norton PT, Ferguson JD, Holmes JW. Effect of ablation pattern on mechanical function in the atrium. Pacing Clin Electrophysiol. 2017;40(6):648-54. 27. Pilote, L, Hüttner I, Marpole D, Sniderman A. Stiff left atrial syndrome. Can J Cardiol. 1988;4(6):255-7. 28. Gibson DN, Di Biase L, Mohanti P, Patel JD, Bai R, Sanchez J, et al: Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011;8(9):1364-71. 29. Wylie JV, Peters DC, Essebag V, Manning WJ, Josephson ME, Hauser TH. Left atrial function and scar after catheter ablation of atrial fibrillation. Heart Rhythm. 2008;5(5):656-62. 30. Sandhu A, Zipse MM, Borne RT, Aleong RG, Tompkins C, Schuller J, et al. Esophageal position, measured luminal temperatures, and risk of atrioesophageal fistula with atrial fibrillation ablation. Pacing Clin Electrophysiol. 2019;42(4):458-63. 31. Aupperle H, Doll N, Walther T, Kornherr P, Ullmann C, Schoon HA, et al. Ablation of atrial fibrillation and esophageal injury: effects of energy source and ablation technique. J Thorac Cardiovasc Surg. 2005;130(6):1549-54. 32. Medeiros De Vasconcelos JT, Filho SDSG, Atié J, Maciel W, De Souza OF, Saad EB, et al. Atrial-oesophageal fistula following percutaneous radiofrequency catheter ablation of atrial fibrillation: the risk still persists. Europace. 2017;19(2):250-8. 33. Scanavacca M. Current atrial fibrillation ablation: an alert for the prevention and treatment of esophageal lesions. Arq Bras Cardiol. 2016;106(5):354-7. 34. Chubb H, Karim R, Roujol S, Nuñez-Garcia M, Williams SE, Whitaker J, et al. The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study. J Cardiovasc Magn Reson. 2018;20(1):21. 35. Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, et al. EACVI/ EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17(4):355-83. 36. Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Approaches to catheter ablation for persistent atrial fibrillation. NEngl J Med. 2015;372(19):1812-22. 37. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498-506. 38. NationalHeart,Lung,andBloodInstitute.ClinicalTrials.gov[Internet].Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter AblationofAtrialFibrillation(DECAAFII).Maryland,USA:NIH;2019[cited17 fev 2018].Available from: https://clinicaltrials.gov/ct2/show/NCT02529319. 634